ClinicalTrials.Veeva

Menu
N

Northern New Jersey Eye Institute | South Orange, NJ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Timolol Maleate
PVP
DE-126
iodine
DE-117
AGN-193408
Iodine
Travoprost
Povidone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease

Dry Eye Disease (DED) refers to a long-term condition that happens when there is not enough lubrication in your eyes. This can happen when your eye c...

Enrolling
Dry Eye Disease
Drug: ABBV-444
Drug: REFRESH OPTIVE UD

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Sham Administration
Drug: AGN-193408 SR

Trial sponsors

AbbVie logo
Glaukos logo
S
Shire logo
Bausch + Lomb logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems